glp-1 receptor medications New Guidelines for Type 2 Diabetes in 2025 GLP-1 Receptor Agonists: An Alternative
Description
After reviewing data submitted to the FDAs Adverse Event Reporting System between 2018 and 2024, McCall and his coauthors found that compounded GLP-1 medicines were correlated with a greater likelihood of abdominal pain, nausea, diarrhea, gallbladder inflammation, and suicidality compared to standard formulations, as well as more frequent hospitalization for those adverse effects
He also outlines his upcoming clinical trial investigating ketogenic therapy for anorexia, offering cautious but meaningful hope for those seeking new science-based treatment options
Read More Confused about GLP-1s
Manage gastrointestinal side effects proactively
Oral GLP-1s simplify distribution and patient access but cause significantly greater complexity upstream in the value chain, creating a distinct set of operational challenges
Acid Reflux Destroys Your Enamel GLP-1 medications slow down how fast your stomach empties
